OxyPhyte Green Tea (Camellia sinensis extract)

OxyPhyte Green Tea is a standardized Camellia sinensis extract rich in epigallocatechin gallate (EGCG), a catechin polyphenol that neutralizes reactive oxygen species and upregulates endogenous antioxidant enzymes. Its primary mechanism involves direct free radical scavenging and modulation of Nrf2-mediated antioxidant pathways, leading to measurable reductions in oxidative stress biomarkers.

Category: Other Evidence: 2/10 Tier: Moderate (some RCTs)
OxyPhyte Green Tea (Camellia sinensis extract) — Hermetica Encyclopedia

Origin & History

OxyPhyte Green Tea is a branded extract derived from the leaves of Camellia sinensis, the tea plant native to East Asia. It contains concentrated polyphenols, primarily catechins like EGCG, obtained through water or ethanol extraction methods designed to preserve bioactive compounds while minimizing oxidation.

Historical & Cultural Context

Green tea from Camellia sinensis has been used in Traditional Chinese Medicine for over 2,000 years to aid digestion, promote detoxification, and treat inflammation-related conditions. Historical texts describe its use for longevity, cardiovascular health, and as an antioxidant tonic.

Health Benefits

• Increases total antioxidant capacity by 0.08-0.43 mmol/L based on meta-analysis of 16 RCTs with 760 participants
• Reduces oxidative stress markers and increases biological antioxidant potential in athletes (one RCT, 16 gymnasts)
• May improve menstrual regulation in women with PCOS (one RCT, 94 women)
• Modulates multiple cellular pathways including Nrf2/ARE/HO-1 for mitochondrial protection (cellular studies)
• Demonstrates anti-inflammatory effects via TLR4/NF-κB pathway inhibition (in-vitro evidence)

How It Works

EGCG and related catechins in Camellia sinensis donate hydrogen atoms to neutralize superoxide, hydroxyl, and peroxyl radicals, directly quenching reactive oxygen species. EGCG also activates the Nrf2-Keap1 transcription pathway, increasing expression of antioxidant enzymes including superoxide dismutase (SOD), catalase, and glutathione peroxidase. Additionally, EGCG inhibits pro-oxidant enzymes such as NADPH oxidase and xanthine oxidase, reducing endogenous ROS generation at the enzymatic level.

Scientific Research

A comprehensive meta-analysis of 16 randomized controlled trials (17 arms, 760 participants) found green tea supplementation significantly increased total antioxidant capacity, though effects on malondialdehyde showed high heterogeneity (PMID: 34829602). Additional RCTs demonstrated reduced oxidative stress in trained athletes using 780 mg green tea catechins and improved menstrual regulation in women with PCOS using 500 mg daily doses.

Clinical Summary

A meta-analysis of 16 randomized controlled trials involving 760 participants demonstrated that green tea catechin supplementation increased total antioxidant capacity by 0.08–0.43 mmol/L, representing a statistically significant and dose-dependent effect. A separate RCT in 16 competitive gymnasts found measurable reductions in oxidative stress markers and increased biological antioxidant potential following supplementation. One RCT with 94 women with polycystic ovary syndrome (PCOS) suggested possible improvements in menstrual regularity, though this finding requires replication in larger trials. Overall, antioxidant evidence is moderately strong given the meta-analytic support, while hormonal and athletic performance benefits remain preliminary.

Nutritional Profile

OxyPhyte Green Tea (Camellia sinensis extract) is a concentrated phytochemical extract, not a whole food source of macronutrients. Primary bioactive compounds include: Catechins (major polyphenols) — typically 45–90% of dry extract weight, comprising EGCG (epigallocatechin-3-gallate, the predominant catechin at 50–75% of total catechins, approximately 200–400 mg per standardized gram of extract), EGC (epigallocatechin), ECG (epicatechin-3-gallate), and EC (epicatechin). Total polyphenol content typically 80–95% by dry weight in high-grade extracts. Caffeine present at approximately 2–5% of extract weight (lower than whole leaf due to processing). L-theanine (amino acid) present in reduced concentrations relative to whole leaf, typically 1–3% in extracts. Flavonols including quercetin, kaempferol, and myricetin glycosides at trace levels (<1% combined). Chlorophyll and carotenoid pigments (lutein, beta-carotene) retained in green tea extracts at minor concentrations. Minerals: fluoride, manganese, potassium, and zinc present at low but measurable concentrations. No significant macronutrient contribution (negligible protein, fat, or carbohydrate at typical dosing). Bioavailability notes: EGCG bioavailability is dose-dependent and limited (approximately 0.1–1% absolute oral bioavailability); absorption improved by 60% in fasted state versus fed state; the 'OxyPhyte' formulation designation suggests potential enhanced delivery technology (e.g., phospholipid complexing or nanoencapsulation), though specific bioavailability enhancement data for this branded extract are not publicly confirmed. Antioxidant capacity linked to the catechin fraction is well-characterized, consistent with the reported 0.08–0.43 mmol/L increase in total antioxidant capacity observed in meta-analysis data.

Preparation & Dosage

Clinically studied doses for green tea extracts range from 500-780 mg per day, often standardized to catechin content. Short-term protocols used 780 mg as a single dose, while longer interventions applied 500 mg daily tablets for several weeks. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Vitamin C, Vitamin E, Quercetin, CoQ10, Resveratrol

Safety & Interactions

Green tea extract is generally well tolerated at standard doses (400–800 mg/day of catechins), but high-dose EGCG supplements exceeding 800 mg/day have been linked to hepatotoxicity, including rare cases of elevated liver enzymes and acute liver injury. EGCG can inhibit intestinal absorption of non-heme iron and may reduce the efficacy of certain medications including warfarin, nadolol, and some chemotherapy agents by modulating CYP450 enzymes and P-glycoprotein transporters. Caffeine content in non-decaffeinated extracts may exacerbate anxiety, insomnia, and hypertension, and can interact additively with other stimulants. Pregnant and breastfeeding women should limit intake due to caffeine exposure and theoretical folate antagonism associated with high EGCG doses.